Delivery Order SPE2DB22D3301-SPE2DB25FY3DS
Award Date
4/14/25
Potential Completion Date
5/5/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,916.78, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML medical products. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 7, 2025. The contract is not designated as a set-aside and is considered an open competition award. AmerisourceBergen...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,916.78, is for the delivery of the product "PHESGO 600-600 MG-20,000 UNIT 10ML." This is a firm fixed-price delivery order contract with an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,458.39 firm fixed-price contract is for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a pharmaceutical product. The contract has a period of performance through March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceutical product. The $10,641.84 firm fixed price contract has an ultimate completion date of November 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical products to support federal healthcare programs and military treatment facilities. This delivery order is part of a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,376,730 units of the pharmaceutical product PHESGO (1,200-600MG-30,000 unit, 15ML) at a ceiling value of $8,159.16. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, with a ceiling value of $10,916.78. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,458.39, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceuticals. It is a firm fixed-price, non-set-aside contract with a performance period ending on May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 600-600 mg - 20,000 unit 10 ml of the pharmaceutical product PHESGO. The award, valued at $21,283.68, has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under any set-aside designation. This delivery order is part of a larger indefinite delivery contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a medication, with a ceiling value of $10,916.78. The contract is a firm fixed-price delivery order with a period of performance ending on May 22, 2025. This order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,833.56 firm fixed price contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen is the prime contractor, and there is no set-aside designation indicated. The contract is part of a larger...